Literature DB >> 6881688

Quantitation of bronchoalveolar lavage with methylene blue.

R P Baughman, C H Bosken, R G Loudon, P Hurtubise, T Wesseler.   

Abstract

Bronchoalveolar lavage yields a return that is composed of lung liquid and lavage liquid in variable and unknown proportions. Concentrations of chemicals and cells in lung liquid have been presented by previous workers in relative terms, sometimes relating them to the albumin content on the assumption that it is comparatively stable. We report here the use of methylene blue in the introduced fluid as an external marker. This allows the dilution, and thus absolute values, to be calculated. We found the concentrations of albumin in lung fluid to be significantly higher in a group of patients with sarcoidosis (0.50 mg/ml +/- 0.40, mean +/- standard deviation) than in a control group (0.15 mg/ml +/- 0.07; p less than 0.02). Absolute cell counts of lymphocytes in lung fluid lavaged from patients with sarcoidosis were higher than those for control patients (154 lymphocytes/ml +/- 98.9 versus 4 +/- 2.6). There was a correlation between the absolute number of lymphocytes and the albumin concentration per milliliter lung liquid (r = 0.71, p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881688     DOI: 10.1164/arrd.1983.128.2.266

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

1.  Microlavage: a technique for determining the volume of epithelial lining fluid.

Authors:  D R Baldwin; R Wise; J M Andrews; D Honeybourne
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

2.  Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples.

Authors:  H M Morrison; J A Kramps; J H Dijkman; R A Stockley
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

3.  Evaluation of albumin as a reference marker of dilution in bronchoalveolar lavage fluid from asthmatic and control subjects.

Authors:  C Ward; M Duddridge; J Fenwick; P V Gardiner; A Fleetwood; D J Hendrick; E H Walters
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

Review 4.  Measurement of soluble proteins in lung secretions.

Authors:  R A Stockley
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

Review 5.  Assessment of drug disposition in the lung.

Authors:  A S Rebuck; A C Braude
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

6.  Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis.

Authors:  A Eklund; E Blaschke
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

7.  Evaluation of a guarded bronchoscopic method for microbial sampling of the lower airways in foals.

Authors:  A M Hoffman; L Viel; C A Muckle; D B Tesarowski
Journal:  Can J Vet Res       Date:  1991-10       Impact factor: 1.310

8.  Branched-chain amino acids are required for the survival and virulence of Actinobacillus pleuropneumoniae in swine.

Authors:  Sargurunathan Subashchandrabose; Rhiannon M LeVeque; Trevor K Wagner; Roy N Kirkwood; Matti Kiupel; Martha H Mulks
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

9.  Systemic immune response of patients with active pulmonary sarcoidosis.

Authors:  R P Baughman; P E Hurtubise
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

10.  Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.

Authors:  C Cabellos; D E MacIntyre; M Forrest; M Burroughs; S Prasad; E Tuomanen
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.